Risk of multiple sclerosis during tumour necrosis factor inhibitor  treatment  for  arthritis: a  population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)

L Dreyer; M Magyari; B Laursen; R Cordtz; F Sellebjerg; H Locht

doi:10.1080/03009742.2016.1207299

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)

L Dreyer, M Magyari, B Laursen, R Cordtz, F Sellebjerg, H Locht

Institut for Klinisk Medicin

Originalsprog	Engelsk
Artikelnummer	PP31
Tidsskrift	Scandinavian Journal of Rheumatology
Vol/bind	45
Udgave nummer	sup128
Antal sider	1
ISSN	0300-9742
DOI	https://doi.org/10.1080/03009742.2016.1207299
Status	Udgivet - 2016

Adgang til dokumentet

10.1080/03009742.2016.1207299

Citationsformater

Dreyer, L., Magyari, M., Laursen, B., Cordtz, R., Sellebjerg, F., & Locht, H. (2016). Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR). Scandinavian Journal of Rheumatology, 45(sup128), [PP31]. https://doi.org/10.1080/03009742.2016.1207299

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis : a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR). / Dreyer, L; Magyari, M; Laursen, B et al.

I: Scandinavian Journal of Rheumatology, Bind 45, Nr. sup128, PP31, 2016.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Dreyer, L, Magyari, M, Laursen, B, Cordtz, R, Sellebjerg, F & Locht, H 2016, 'Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)', Scandinavian Journal of Rheumatology, bind 45, nr. sup128, PP31. https://doi.org/10.1080/03009742.2016.1207299

@article{802dd9f71c96434bb8f99ad7d4dedf6a,

title = "Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)",

author = "L Dreyer and M Magyari and B Laursen and R Cordtz and F Sellebjerg and H Locht",

year = "2016",

doi = "10.1080/03009742.2016.1207299",

language = "English",

volume = "45",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "sup128",

}

TY - ABST

T1 - Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis

T2 - a population-based study from DANBIO and the Danish Multiple Sclerosis Registry (DMSR)

AU - Dreyer, L

AU - Magyari, M

AU - Laursen, B

AU - Cordtz, R

AU - Sellebjerg, F

AU - Locht, H

PY - 2016

Y1 - 2016

U2 - 10.1080/03009742.2016.1207299

DO - 10.1080/03009742.2016.1207299

M3 - Conference abstract in journal

SN - 0300-9742

VL - 45

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - sup128

M1 - PP31

ER -